We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Durect Corp
23 own
32 watching
Current Price
$1.51
$-0.03
(-1.95%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
18.87M
52-Week High
3.14000
52-Week Low
0.47000
Average Volume
0.02M
Dividend Yield
--
P/E Ratio
--
Market Capitalization18.87M52-Week High3.1400052-Week Low0.47000Average Volume0.02MDividend Yield--P/E Ratio--What does the Durect Corp do?
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and drug delivery programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for experimental research in mice, rats, and other laboratory animals; and a range of biodegradable polymers for use as raw materials for pharmaceutical and medical devices under the LACTEL brand. Its product pipeline consists of multiple investigational drug candidates in clinical development, such as DUR-928, an endogenous, orally bioavailable small molecule that is in Phase 1 development stage to play a regulatory role in lipid homeostasis, inflammation, and cell survival. The company's advanced oral, injectable, and transdermal delivery technologies are designed to enable new indications and enhanced attributes for small-molecule and biologic drugs, including POSIMIR, an investigational analgesic product intended to deliver bupivacaine to provide up to 3 days of pain relief after surgery; and REMOXY ER, an investigational extended release pain relief drug. DURECT Corporation markets and sells its ALZET and LACTEL product lines through direct sales force in the United States, as well as through a network of distributors in Japan, Europe, and internationally. The company has collaboration agreements with Santen Pharmaceutical Co., Ltd.; Impax Laboratories, Inc.; Zogenix, Inc.; and Pain Therapeutics, Inc. DURECT Corporation was founded in 1998 and is headquartered in Cupertino, California.
Read More
How much money does Durect Corp make?
News & Events about Durect Corp.
PR Newswire
1 year ago
DURECT Announces Peer-Reviewed Article Accepted for Publication with Additional Data from Previously Completed Phase 2a Study of Larsucosterol in Alcohol-Associated Hepatitis DURECT Announces Peer-Reviewed Article Accepted for Publication with Additional Data from Previously Completed Phase 2a...
PR Newswire
1 year ago
DURECT Corporation to Announce Third Quarter 2022 Financial Results and Provide Business Update on November 2 DURECT Corporation to Announce Third Quarter 2022 Financial Results and Provide Business Update on November 2 PR Newswire CUPERTINO, Calif., Oct. 26, 2022 CUPERTINO, Calif., Oct. 26, 2022...
PR Newswire
1 year ago
DURECT Reaches Enrollment Milestone in Phase 2b AHFIRM Trial DURECT Reaches Enrollment Milestone in Phase 2b AHFIRM Trial PR Newswire CUPERTINO, Calif., Oct. 6, 2022 AHFIRM enrollment surpasses 200 of the planned 300 AH patients Enrollment completion now anticipated in Q2 2023CUPERTINO, Calif...
PR Newswire
1 year ago
Innocoll and DURECT Announce U.S. launch of POSIMIR Innocoll and DURECT Announce U.S. launch of POSIMIR PR Newswire ATHLONE, Ireland and CUPERTINO, Calif., Sept. 26, 2022 POSIMIR is now commercially available in the U.S. for the treatment of post-surgical pain in adults following arthroscopic...
PR Newswire
2years ago
DURECT Corporation Appoints Timothy M. Papp as Chief Financial Officer DURECT Corporation Appoints Timothy M. Papp as Chief Financial Officer PR Newswire CUPERTINO, Calif., July 5, 2022 CUPERTINO, Calif., July 5, 2022 /PRNewswire/ --DURECT Corporation(Nasdaq: DRRX), a biopharmaceutical company...
Frequently Asked Questions
Frequently Asked Questions
What is Durect Corp share price today?
Can Indians buy Durect Corp shares?
How can I buy Durect Corp shares from India?
Can Fractional shares of Durect Corp be purchased?
What are the documents required to start investing in Durect Corp stocks?
What is today’s traded volume of Durect Corp?
What is today’s market capitalisation of Durect Corp?
What is the 52-Week High and Low Range of Durect Corp?
What percentage is Durect Corp down from its 52-Week High?
What percentage is Durect Corp up from its 52-Week Low?
Current Price
$1.51
$-0.03
(-1.95%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.